Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
D000368:Aged; D000596:Amino Acids / Q000652:urine; D015519:Bone Density; D001862:Bone Resorption; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015994:Incidence; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D017698:Postmenopause; D000068296:Risedronic Acid; D016103:Spinal Fractures / Q000150:complications / Q000453:epidemiology*
D000596:Amino Acids; D010919:Placebos; C036020:deoxypyridinoline; D000068296:Risedronic Acid; D012968:Etidronic Acid